

Airtime: ET
Discussing the rationale for the new ChiNext in Shenzhen, Neil Katkov, senior vice president, Asia research at Celent says the Nasdaq-style start-up board is likely to have a bumpy ride due to overpriced IPOs and declining value. He speaks to CNBC's Martin Soong and Cheng Lei.

